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Context: Mutations in LAMB2, encoding the basement membrane protein, laminin β2,
are associated with an autosomal recessive disorder characterized by congenital nephrotic
syndrome, ocular abnormalities, and neurodevelopmental delay (Pierson syndrome).
Case description: This report describes a 12-year-old boy with short stature, visual
impairment, and developmental delay who presented with macroscopic hematuria
and albuminuria. He had isolated growth hormone deficiency, optic nerve hypoplasia,
and a small anterior pituitary with corpus callosum dysgenesis on his cranial magnetic
resonance imaging, thereby supporting a diagnosis of optic nerve hypoplasia syndrome.
Renal histopathology revealed focal segmental glomerulosclerosis. Using next-generation
sequencing on a targeted gene panel for steroid-resistant nephrotic syndrome, compound
heterozygous missense mutations were identified in LAMB2 (c.737G>A p.Arg246Gln,
c.3982G>C p.Gly1328Arg). Immunohistochemical analysis revealed reduced glomerular
laminin β2 expression compared to control kidney and a thin basement membrane on
electron microscopy. Laminin β2 is expressed during pituitary development and Lamb2–/– mice
exhibit stunted growth, abnormal neural retinae, and here we show, abnormal parenchyma
of the anterior pituitary gland.
Conclusion: We propose that patients with genetically undefined optic nerve hypoplasia
syndrome should be screened for albuminuria and, if present, screened for mutations in LAMB2.
(J Clin Endocrinol Metab 105: 595–599, 2020)
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O

ptic nerve hypoplasia syndrome (ONH) (also referred to as septo-optic dysplasia, SOD) represents
a clinical spectrum associated with visual, pituitary, and
severe central nervous system structural abnormalities
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(1, 2). Traditionally, the cardinal features of the controversial term, SOD, involved 2 or more of the following:
(1) pituitary hypoplasia with isolated or combined pituitary hormone deficiencies, (2) ONH, and/or (3) midline
Abbreviations: DAB, 3,3’-diaminobenzidine; HESX1, homeobox expressed in embryonic stem cells 1; GBM, glomerular basement membrane; LAMB2, laminin β2; SOD,
septo-optic dysplasia; SOX2, SRY (sex-determining region Y)-related HMG box 2; OTX2,
orthodenticle homeobox 2
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Methods
Ethics approval was obtained from the Great Ormond
Street Hospital NHS Foundation Trust. Following informed consent for genetic testing, targeted next-generation
sequencing of ACTN4, ADCK4, CD2AP, COQ2, COQ6,
INF2, ITGA3, LAMB2, LMX1B, MYO1E, NPHS1, NPHS2,
PDSS2, PLCE1, PTPRO, SMARCAL1, TRPC6, and WT1
was undertaken for nephrotic syndrome and HESX1. Patient
and control kidney sections were stained with anti–laminin
β2 (1:500, AMAb91096, Atlas) and anti-Podocin antibodies
(1:100, P0372, Sigma) as previously described (3). Pituitary
tissue of Lamb2–/– and Lamb2+/+ mice (4) were stained with
hematoxylin and eosin (H&E) and 3,3’-diaminobenzidine
(DAB) as previously described (3).

Case History
A male infant presented at age 4 months with roving
eye movements and impaired visual function. Born at
35 weeks’ gestation to a healthy mother age 33 years, he
weighed 1.93 kg (–1.47 SD score [SDS]) and measured
42 cm (–2.13 SDS). No exposure to recreational drugs,
alcohol, or prescription medications was reported, and
his parents were nonconsanguineous. By age 31 months,
he had global developmental delay with marked hypotonia. Cranial magnetic resonance imaging revealed bilateral hypoplastic intraorbital optic nerves and anterior
pituitary hypoplasia with a global reduction of white

matter. The bulk of the posterior corpus callosum was
reduced (Fig. 1A). The septum pellucidum was present.
At age 5 years, he presented with recurrent macroscopic hematuria associated with hypoalbuminemia
(25 g/L) and significant albuminuria (urine albumin
to creatinine ratio was 1329 mg/mmol) with normal
renal function. A renal biopsy showed focal segmental
glomerulosclerosis (FSGS) and a thin, lamellated glomerular basement membrane (GBM) with podocyte foot
process effacement (Fig. 1B).
On follow-up, the patient had short stature: His
height was 117.7 cm (–1.4 SDS) with a weight of 18.5 kg
(–2.54 SDS) at the chronological age of 7.9 years (Fig. 1C).
Investigations revealed a low insulin-like growth factor 1
(IGF1) of 29 ng/mL and normal insulin-like growth
factor–binding protein 3 (2.48 ng/L), normal thyroxine
and thyrotropin, with a low free 3,5,3′-triiodothyronine
of 5.3 pmol/L (6.2-9.5 pmol/L). A glucagon stimulation
test revealed a peak GH concentration of 4.5 μg/L, suggesting GH insufficiency. At the start of the test, the basal
glucose was 2.8 mmol/L with a nadir of 2.3 mmol/L,
reflecting significant hypoglycemia. The peak cortisol
to glucagon stimulation testing was normal, measuring
819 nmol/L. Measured prolactin concentrations ranged
between 80 and 244 mU/L (normal: 44-479 mU/L). At
a chronological age of 10.5 years, the patient’s bone
age was delayed at 9 years, and therefore the low IGF1
could not be solely accounted for by undernutrition.
Given the features of GH insufficiency along with his
poor height velocity at 3.7 cm per year with a low IGF1
and neuroradiological findings, daily subcutaneous GH
injections at 10 IU/m2/week were commenced (Fig. 1C).
Following commencement of GH, his growth rate initially improved to 6.6 cm per year from a growth rate
of 3.7 cm per year before commencement of GH. We
suspect that adherence to GH treatment may have been
an issue initially. Following transfer of the patient’s
care to his grandparents, the excellent growth rate observed from age 12 years occurred while he was still
prepubertal. At age 12.74 years, his height velocity was
10.6 cm per year, with pubertal ratings of G2 P1 A1 and
testicular volumes of 2 mL on the right and 3 mL on the
left. His bone age at that stage was 10.4 years.
Genetic testing for nephrotic syndrome revealed compound heterozygous missense mutations in LAMB2, the
gene encoding laminin β2, a structural component of
the GBM, previously implicated in Pierson syndrome
(OMIM 609049) (5) (Fig. 1D). One mutation in exon
7 (c.737G>A, p.Arg246Gln) was originally reported
(5), and the other, identified in exon 25 (c.3982 G>C,
p.Gly1328Arg), was novel. Both variants were predicted
to be deleterious to protein function using PolyPhen and
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brain defects. Risk factors include maternal exposure to
recreational or prescription drugs, alcohol, diabetes, and
viral infection. Mutations in genes encoding transcription factors that regulate eye, forebrain, and pituitary
development have been identified in a small proportion
of patients with ONH with hypopituitarism (1). HESX1
homeobox 1 (HESX1) encodes a homeobox protein involved in forebrain and early pituitary development in
mice. Mutations in HESX1 account for less than 1%
of hypopituitarism ± ONH. An increasing number of
genes implicated in ONH have been reported and include other transcription factors important for eye and
forebrain development (OTX2, SOX2, PAX6, NR2F1,
VAX1, and ATOH7), whereas others identified regulate cellular processes such as RNA splicing, chromatin
remodeling, and the microtubular network (1).
Compound heterozygous mutations in LAMB2,
encoding laminin β2, an extracellular matrix glycoprotein, were herein identified in a patient with 3 cardinal
features of an ONH associated with growth hormone
(GH) deficiency phenotype who also had proteinuric
kidney disease. Screening for albuminuria may lead to
further identification of LAMB2 mutations in genetically undefined ONH diagnoses.
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Figure 1. A, Sagittal T1-weighted imaging (WI) of the pituitary region shows a small adenohypophysis (WI) (arrow in A), with a normal T1 posterior
hyperintense focus corresponding to the neurohypophysis (dotted arrow in A). Note the reduction of the bulk of the posterior aspect of the corpus
callosum. Axial T2-WI shows a dysplastic cortex in the right anterior temporal and insular regions (arrows in B). Axial T2-WI of the orbits shows small
optic nerves (arrows in C) and bilateral buphthalmos. B, Hematoxylin and eosin (H&E) and periodic acid–Schiff (PAS) staining of patient renal biopsy
sections: a and b, H&E shows segmental sclerosis, narrowing of the Bowman space, and adhesions to its capsule; c, PAS staining shows mesangial
proliferation with diffuse sclerosis and obliteration of the tip of the capillary tuft; d, Electron microscopy reveals a thin, lamellated glomerular
basement membrane (GBM) and podocyte foot process effacement; scale bar 50 μm. C, Growth chart showing height (cm) and weight (kg) of
the proband from ages 1 to 14 years; initiation of growth hormone (arrow). D, Sanger sequencing confirmed compound heterozygous LAMB2
mutations: c.737G>A, Chr3: g.49168561C>T, p.Arg246Gln and c.3982G>C, Chr3:g.49160880C>G, and p.Gly1328Arg. E, Location of LAMB2detected variants at the level of exons and protein. The c.737G>A variant is located in exon 7 encoding part of the laminin N-terminal (LN′) domain,
whereas the c.3982G>C variant is located in exon 25 encoding part of the laminin coiled–coil domain (LCC′) of laminin β2 protein. The LN′ domain
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Discussion
Following presentation with recurrent macroscopic
hematuria and albuminuria, compound heterozygous
mutations in LAMB2, encoding laminin β2, were identified in a boy with short stature, visual impairment, and
developmental delay. Investigations revealed ONH associated with anterior pituitary hypoplasia and GH deficiency. Although the septum pellucidum was present,
dysgenesis of the posterior corpus callosum was evident,
thereby supporting the traditional diagnosis of ONH
with GH deficiency and midline defects. Several publications have highlighted that ONH with hypopituitarism
now represents a spectrum of developmental defects
involving the eye, neural retina, and forebrain (including
the pituitary) with a range of midline defects that do not
always involve an absent septum pellucidum.
Albuminuria associated with FSGS has not yet
been reported in the ONH spectrum. Interestingly,
nonsense and truncating mutations in LAMB2 are
associated with Pierson syndrome, an autosomal recessive disorder characterized by congenital nephrotic syndrome, ocular abnormalities (commonly
microcoria), muscular hypotonia, and neurological
deficits (5, 6). Indeed, Pierson syndrome may be
within the ONH spectrum. Hypomorphic missense
mutations have been reported with milder phenotypes, manifesting later in childhood, whereby defective secretion of the mutant laminin β2–trimer
leads to compromised GBM integrity (7). The other
variant (p.G1328R) is a novel missense mutation,

Figure 2. Hematoxylin and eosin (H&E) and 3,3’-diaminobenzidine
(DAB) immunostaining of pituitary gland sections from wild-type
and knockout Lamb2 mice. A, The upper row shows H&E staining of
anterior pituitary sections from Lamb2+/+ mice, which show uniform
staining across the gland. The lower row shows anterior pituitary
sections from the Lamb2–/– mice, which show evidence of abnormal
cell staining, seen as randomly distributed patches of unstained
cells (indicated with arrow heads), imaged at magnifications of 5×
(left) and 20× (right); scale bar of 500 μm and 200 μm, respectively.
B, Growth hormone (GH) DAB immunostaining confirmed the
abnormality of these cell clusters in Lamb2–/– pituitary sections, which
show negative staining for GH (lower row; indicated with arrow
heads) compared to Lamb2+/+ mice (upper row); scale bar of 500 μm.

in which glycine is replaced by an arginine at amino
acid 1328 in the coiled coil domain of the peptide.
Supporting evidence for a pathogenic mutant laminin β2 protein was the finding of a thin GBM on
electron microscopy and reduced glomerular laminin
β2 expression on patient kidney sections.
To date, genes implicated in ONH play a role in the
transcriptional regulation of pituitary and forebrain

is responsible for laminin trimer polymerization to form the basement membrane. The LCC′ domain is involved in the assembly of individual laminin
α, β, and γ chains into trimers. F, Conservation of the LAMB2 amino acids that are altered in the patient: c.737G>A and c.3982G>C (upper and
lower rows, respectively) alongside disparately related species. G, Dual immunofluorescence staining of laminin β2 in a patient renal biopsy (LAMB2
737G>A/ 3983G>C; mutant) compared to time zero protocol renal transplant biopsy (LAMB2+/+; control). The figure shows reduced expression of
laminin β2 (red) in the mutant, seen in a reduced thickness and integrity and/or continuity of the GBM compared to the control.
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SIFT software analyses (Fig. 1E) and affected highly
conserved amino acids (Fig. 1F). No mutations were
detected in HESX1, and the clinical phenotype did not
match that documented for SOX2 or OTX2 mutations.
Reduced glomerular expression of laminin β2 was observed in the patient biopsy compared to the control
(Fig. 1G).
H&E staining of pituitary sections of Lamb2–/– mice
suggested abnormal morphology of the anterior pituitary parenchyma, exhibited by cellular clusters that
were not evident in their wild-type littermates (Fig. 2A).
Somatropin signal was absent in Lamb2–/– compared to
Lamb2+/+ pituitaries (Fig. 2B). Because the patient had
isolated GH deficiency, analysis of other pituitary cell
types was not undertaken.
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development (1). In situ hybridization studies have revealed expression of laminin isoforms throughout pituitary morphogenesis (8, 9). In early murine gestation,
laminin β2 messenger RNA is expressed in the epithelium
of the Rathke pouch and by mid-gestation within the
pars distalis and tuberalis (9). Expression later extends
to the parenchyma and marginal cell layers of the anterior and intermediate pituitary lobes as well as the vasculature of the anterior lobe, both in late gestation and
the early postnatal period (9). Laminin β2 expression is
observed within the parenchyma and vasculature of the
anterior lobe in the adult pituitary (9).
Our examination of Lamb2–/– mice revealed abnormal parenchymal morphology of the anterior
pituitary compared to controls, and Lamb2–/– mice
exhibit stunted growth (4, 10). Further investigations
involving assessment of pituitary function with measurement of GH levels will be of interest. In Lamb2–
/–
mice the outer segment of the rod photoreceptor
layer is associated with disorganized synapses in the
outer plexiform layer and a reduced physiological
response (4, 10). Human and murine findings both
support the proposal that mutations in LAMB2 may
underlie genetically undefined ONH, and urine dipstick testing may alert the clinician to screen for mutations in LAMB2.
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